Radius Announces European Medicines Agency Validates Marketing Authorization Application for Abaloparatide-SC for the Treatment of ...
Radius Initiates Human Pharmacokinetic Study of Optimized Transdermal Patch of Investigational Drug Abaloparatide WALTHAM, Mass., Dec. 04, 2015 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS), today announced that the European Medicines Agency (EMA) has …